Literature DB >> 4886629

Pathogen-free isolation unit--three years' experience.

M Schneider, L Schwarzenberg, J L Amiel, A Cattan, J R Schlumberger, M Hayat, F De Vassal, C Jasmin, C Rosenfeld, G Mathé.   

Abstract

The results obtained during the first three years of a pathogen-free isolation unit containing five beds have shown that this type of unit can reduce the risk of infection in patients treated with intensive chemotherapy or in those who have granulocytopenia from various causes. It is suggested that treatment of cancer which involves these risks should be carried out routinely in sterile isolation units, and that it is urgent to build many more and much larger units.

Entities:  

Mesh:

Year:  1969        PMID: 4886629      PMCID: PMC1982443          DOI: 10.1136/bmj.1.5647.836

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  [Bacterial and fungus infections during the course of acute leukemias].

Authors:  M Schneider
Journal:  Sem Hop       Date:  1967-02-08

2.  The nature and control of infections in patients with acute leukemia.

Authors:  E Frei; R H Levin; G P Bodey; E E Morse; E J Freireich
Journal:  Cancer Res       Date:  1965-10       Impact factor: 12.701

3.  The use of an isolator system in cancer chemotherapy.

Authors:  A A Levitan; S Perry
Journal:  Am J Med       Date:  1968-02       Impact factor: 4.965

Review 4.  [Hematologic resuscitation. II. Correction of severe leukocyte and immune globulin disorders. The bone marrow graft].

Authors:  L Schwarzenberg; A Cattan; M Schneider; J R Schlumberger; J L Amiel; G Mathé
Journal:  Presse Med       Date:  1966-04-23       Impact factor: 1.228

5.  [The treatment of agranulocytosis].

Authors:  A Cattan
Journal:  Presse Med       Date:  1966-04-23       Impact factor: 1.228

6.  [The symptomatic treatment of agranulocytosis by leukocyte transfusion].

Authors:  L Schwarzenberg; G Mathe; J L Amiel; A Cattan; M Schneider; J R Schlumberger
Journal:  Presse Med       Date:  1966-04-23       Impact factor: 1.228

  6 in total
  5 in total

1.  The multiplication of analogs, the best strategy for rapid extension of the oncostatic arsenal. How can they be compared experimentally?

Authors:  G Mathé; C Jasmin
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Clinical use of reverse isolation in a protected environment.

Authors:  M Bláha; J Vanásek; V Mĕrka; M Splino; J Malý; O Siroký
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

3.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukaemia patients. III: The quality of isolation and decontamination.

Authors:  J Dankert; W Gaus; H Gaya; D Krieger; G Linzenmeier; D van der Waaij
Journal:  Infection       Date:  1978       Impact factor: 3.553

4.  Biotyping of Enterobacteriaceae as a test for the evaluation of isolation systems.

Authors:  D van der Waaij; T M Speltie; J M Vossen
Journal:  J Hyg (Lond)       Date:  1972-12

5.  The importance of cleanrooms for the treatment of haemato-oncological patients.

Authors:  Ondřej Holý; Ivanka Matoušková
Journal:  Contemp Oncol (Pozn)       Date:  2012-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.